Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 5.31 is 41% below its 5-year average of 9.03, near the low end of its 5-year range (0.26–45.30).
As of the fiscal period ended Tuesday, June 30, 2026. 93.68% above its 12-month average of 2.74.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.31.
CURRENT RATIO
5.31
CURRENT RATIO AVG TTM
2.74
CURRENT RATIO AVG 3Y
3.14
CURRENT RATIO AVG 5Y
9.03
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+93.68%
CURRENT VS 3Y AVG
+69.14%
CURRENT VS 5Y AVG
-41.14%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.59
median of 798 covered companies
CURRENT VS SECTOR MEDIAN
+47.80%
vs the sector median at left
Rani Therapeutics Holdings, Inc.
Market Cap
$51.24M
Current Ratio
5.31
TTM Avg
2.74
3Y Avg
3.14
5Y Avg
9.03
Market Cap
$51.54M
Current Ratio
3.74
TTM Avg
0.21
3Y Avg
0.34
5Y Avg
1.39
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rani Therapeutics Holdings, Inc. (RANI) | $51.24M | 5.31 | 2.74 | 3.14 | 9.03 |
| Envoy Medical, Inc. (COCH)vs › | $51.33M | 1.73 | 0.89 | 0.86 | 0.91 |
| eXoZymes, Inc. (EXOZ)vs › | $51.42M | 3.81 | 5.31 | 3.36 | 3.21 |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.54M | 3.74 | 0.21 | 0.34 | 1.39 |
| biote Corp. (BTMD)vs › | $51.61M | 1.43 | 1.27 | 3.36 | 3.09 |
| Celularity Inc. (CELU)vs › | $50.51M | 0.09 | 0.27 | 0.34 | 1.05 |
| Clene Inc. (CLNN)vs › | $50.67M | 3.07 | 1.20 | 1.51 | 3.42 |
| Apollomics, Inc. (APLM)vs › | $50.18M | 0.96 | 1.17 | 2.45 | 5.02 |
| INmune Bio, Inc. (INMB)vs › | $50.25M | 4.04 | 3.34 | 3.69 | 7.87 |
| Microbot Medical Inc. (MBOT)vs › | $50.13M | 18.56 | 12.85 | 8.01 | 9.80 |
Current Ratio
5.31
Quick Ratio
5.31
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 5.31 |
| 2026-03-31 | 3.40 |
| 2025-12-31 | 4.21 |
| 2025-09-30 | 0.26 |
| 2025-06-30 | 0.54 |
| 2025-03-31 | 0.88 |
| 2024-12-31 | 1.50 |
| 2024-09-30 | 1.60 |
| 2024-06-30 | 1.93 |
| 2024-03-31 | 3.09 |
| 2023-12-31 | 6.36 |
| 2023-09-30 | 8.61 |
| 2023-06-30 | 13.32 |
| 2023-03-31 | 17.29 |
| 2022-12-31 | 20.96 |
| 2022-09-30 | 14.02 |
| 2022-06-30 | 18.32 |
| 2022-03-31 | 26.29 |
| 2021-12-31 | 45.30 |
| 2021-09-30 | 25.21 |
| 2021-06-30 | 7.43 |
| 2021-03-31 | 10.84 |
| 2020-12-31 | 14.12 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
